Covered recipient · General Payments record
JOEL FEINSTEIN
General Payments · PY2018–2024
$1,473.30
- Reported across 60 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $422.74 | 15 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| GENZYME CORPORATION | $114.14 | 3 |
| PFIZER INC. | $106.51 | 5 |
| Phathom Pharmaceuticals, Inc. | $87.78 | 3 |
| Regeneron Healthcare Solutions, Inc. | $31.76 | 1 |
| ABBVIE INC. | $31.63 | 1 |
| Janssen Biotech, Inc. | $28.73 | 1 |
| Merck Sharp & Dohme Corporation | $22.19 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (15)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $31.63 | 10/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103717942 | CMS |
| GENZYME CORPORATION | $28.27 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139861018 | CMS |
| GENZYME CORPORATION | $46.10 | 09/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139861072 | CMS |
| GENZYME CORPORATION | $39.77 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139861080 | CMS |
| Janssen Biotech, Inc. | $28.73 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078308348 | CMS |
| Merck Sharp & Dohme LLC | $22.19 | 01/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141718724 | CMS |
| PFIZER INC. | $23.57 | 02/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131182736 | CMS |
| PFIZER INC. | $25.77 | 04/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131392683 | CMS |
| PFIZER INC. | $18.59 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131490713 | CMS |
| PFIZER INC. | $24.09 | 10/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132104161 | CMS |
| PFIZER INC. | $14.49 | 12/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131406647 | CMS |
| Phathom Pharmaceuticals, Inc. | $33.49 | 07/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151060481 | CMS |
| Phathom Pharmaceuticals, Inc. | $27.35 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151060483 | CMS |
| Phathom Pharmaceuticals, Inc. | $26.94 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151060485 | CMS |
| Regeneron Healthcare Solutions, Inc. | $31.76 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114046434 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.